Carlisle Companies Incorporated (CSL)

Pretax margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Earnings before tax but after interest (EBT) US$ in thousands 1,110,900 930,400 1,195,600 482,500 404,200
Revenue US$ in thousands 5,003,600 4,586,900 6,591,900 4,810,300 3,969,900
Pretax margin 22.20% 20.28% 18.14% 10.03% 10.18%

December 31, 2024 calculation

Pretax margin = EBT ÷ Revenue
= $1,110,900K ÷ $5,003,600K
= 22.20%

The pretax margin of Carlisle Companies Incorporated has shown a positive trend over the past five years, steadily increasing from 10.18% in December 31, 2020, to 22.20% in December 31, 2024. This indicates that the company has been able to effectively control its operating expenses and generate higher pre-tax profits relative to its total revenue. The significant improvement in pretax margin from 2022 to 2024 suggests enhanced operational efficiency and effectiveness in managing costs. This positive trend in pretax margin demonstrates Carlisle Companies' ability to optimize its profitability and financial performance over the years.


Peer comparison

Dec 31, 2024

Company name
Symbol
Pretax margin
Carlisle Companies Incorporated
CSL
22.20%
West Pharmaceutical Services Inc
WST
20.24%